Search Results 541-550 of 18145 for Lymphocytic leukemia

  1. Clinical trials - Oncology (Medical)

    ... lymphocytic leukemia (CLL) risk across African Americans, Hispanics, and Caucasian populations. A Study to Evaluate Olaparib and Temozolomide in Treating ...

  2. Clinical trials - Oncology (Medical)

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  3. Health Topics - Mayo Clinic News Network

    3 facts about acute lymphocytic leukemia in children featured image. Cancer. 3 facts about acute lymphocytic leukemia in children. Nicole Ferrara. September 21 ...

  4. Publications - Pedro Horna, M.D. - Mayo Clinic

    Recurrent Chromosomal Abnormalities in Tissues Involved by Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Am J Clin Pathol. 2022 Feb 3; 157 (2): ...

  5. Cancer treatment - Mayo Clinic

    Related. Acute lymphocytic leukemia · Acute myelogenous leukemia · Alternative cancer treatments: 11 options ...

  6. Clinical trials - Oncology (Medical)

    ... lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not ...

  7. Leukemia - Doctors and departments - Mayo Clinic

    Oncologist. Jacksonville, FL. Areas of focus: CAR-T cell therapy, Multiple myeloma, Leukemia, Chronic lymphocytic leukemia, Waldenstrom macroglobulinemia, ...

  8. Hematology - Doctors - Mayo Clinic

    ... lymphocytic leukemia, M...yelodysplastic syndromes, Myelofibrosis, Acute myelogenous leukemia, Chronic myelogenous leukemia, Aplastic anemia, Leukemia ...

  9. Hematology - Doctors - Mayo Clinic

    ... lymphocytic leukemia, M...yelodysplastic syndromes, Myelofibrosis, Acute myelogenous leukemia, Chronic myelogenous leukemia, Aplastic anemia, Leukemia ...

  10. Efficacy And Safety Of Nemtabrutinib (MK-1026) In Participants With Hematologic Malignancies (MK-1026-003) - Mayo Clinic

    ... lymphocytic leukemia/ Small lymphocytic lymphoma (CLL/SLL) with * At least 2 lines of prior therapy (Part 1 only) * Part 2 Cohort A: CLL/SLL participants ...